| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |